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WHAT IS ALREADY KNOWN ABOUT
THIS SUBJECT
• Care home residents are a frail and
vulnerable population who are at a high risk
of adverse drug reactions.
• The recording of drug sensitivities is
important to avoid the inadvertent
prescribing, dispensing and administration
of an offending drug to a sensitive resident.
• There have been no studies investigating
the recording of drug sensitivities for care
home residents.
WHAT THIS STUDY ADDS
• The recording of drug sensitivities for care
home residents is suboptimal and there are
large discrepancies between records.
• It is concerning that over 90% of
sensitivities are not recorded on the care
home medicines administration record.
• Systems improvements are required,
including the sharing of drug sensitivity
status with community pharmacists; this
could be achieved by printing sensitivities
on prescriptions.
AIMS
The aims of this study were to determine the recording of drug
sensitivities of elderly care home residents, to describe the nature of
sensitivities and to identify and describe discrepancies in the
documentation of drug sensitivity status in general practices,
pharmacies and care homes.
METHODS
A random sample of residents within a purposive sample of care
homes (nursing and residential) was selected. A clinical pharmacist
inspected the GP medical record, the medicines administration
record, and the care home record for each resident to identify drug
sensitivities and discrepancies between records and to describe the
nature of the recorded sensitivities.
RESULTS
The records of 121 residents in 31 care homes were studied. Thirty-one
(26%) residents had at least one documented drug sensitivity in one
of the sources inspected, with 48 sensitivities in total recorded. There
was no description of the nature of the sensitivities recorded in 39/48
(81%) cases. The number of sensitivities recorded on the medicines
administration record, care home record and the GP record were 3
(6%), 29 (60%) and 35 (73%), respectively. Only two sensitivities were
simultaneously recorded on all three records.
CONCLUSIONS
It was of concern that over 90% of drug sensitivities were not recorded
on the medicines administration record which is the final checking
document when administering medication. The reason for this was
that the dispensing pharmacy was responsible for generating the
medicines administration record; however, drug sensitivity status is
seldom shared between the GP and the dispensing pharmacy. Printing
sensitivities on prescriptions would help to resolve this.
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Introduction
A patient is deemed to be sensitive to a drug if they have
had a previous adverse drug reaction to the drug, or to a
similar drug. An adverse drug reaction is ‘a response to a
medicine which is noxious and unintended, and which
occurs at doses normally used in man’ [1]. Adverse drug
reactions can be classified into two broad categories [2].
Type A (augmented) reactions are related to the pharma-
cology of the drug and are therefore, dose-related and
predictable (e.g. hypotension with antihypertensive medi-
cation). Type B reactions are unrelated to the pharmacol-
ogy of the drug and consequently are not dose-related.
Type B reactions include immunologically-mediated reac-
tions (allergies) such as anaphylaxis with penicillins [2].
If patients are administered medicines that they are
sensitive to, then there is a risk of severe harm including
death [3]. A report in 2004 by the UK Department of
Health on improving medication safety in the NHS high-
lighted the potential harm of drug allergies and issued
guidance to reduce risk [4]. This included that the allergy
status should be documented on all hospital charts used
for prescribing medicines to be visible at the point of pre-
scribing, dispensing and administration, symptoms of any
reported allergies should be documented and drug
allergy should be recorded on the general practice com-
puter in a way that will trigger an alert if an attempt is
made to prescribe the offending drug [4]. However, there
are no guidelines as to how drug allergies or other types
of sensitivities should be recorded within care homes or
community pharmacies.
The typology and description of the nature of drug
sensitivities is important because some may be relatively
minor and/or can be addressed by taking precautions, e.g.
prescribing a lower dose, prescribing additional therapy,
conducting biochemical monitoring, etc. However, in the
case of true allergies, the drug is contra-indicated. The
nature and severity of drug sensitivities is also important
to ensure beneficial medicines are not unnecessarily
avoided in the future.
Care home residents are old, frail and vulnerable and
are more susceptible to adverse drug reactions and their
consequences than other members of society due to
altered pharmacodynamics and pharmacokinetics [2]. In
addition, two-thirds to three-quarters of care home resi-
dents may have cognitive impairment and this may
impede their ability to communicate problems with medi-
cines to their carers [5, 6]. Consequently, the recording of
drug sensitivities for this population is paramount to
avoid the inadvertent administration of potentially
harmful medicines. The recording of sensitivities in sec-
ondary care has been found to be suboptimal [7–12]. We
were unable to locate any studies investigating the
recording of drug sensitivities in primary care. This is the
first study to investigate drug sensitivity recording for care
home residents.
In the UK, care homes may provide personal care (resi-
dential homes), 24 h nursing care (nursing homes) or both.
They are regulated and inspected by the Care Quality Com-
mission and are assessed against national minimum stan-
dards, one of which pertains to the use of medicines [13].
The Care Quality Commission and the Royal Pharmaceuti-
cal Society of Great Britain produce guidance on the man-
agement of medicines in care homes [14, 15].The National
Service Framework for Older People states that people
aged 75 years or older should have their medicines
reviewed every 12 months, with those on four or more
medicines requiring a 6-monthly review [16]. In practice,
the majority of care home residents in the UK qualify for a
6-monthly medication review.
The objectives of this study were to i) determine the
proportion of elderly care home residents with a docu-
mented drug sensitivity, ii) describe the nature of the
documented sensitivity and iii) identify and describe dis-
crepancies in record keeping of drug sensitivity status in
elderly care home residents.
Methods
Ethical approval was obtained from the Central Office for
Research Ethics Committee. A sub-sample of residents
from one geographical area from the Care Homes’ Use of
Medicines study was identified. The Care Homes’ Use of
Medicines study was a major study of medication errors
in UK care home residents [17]. Care homes were purpo-
sively sampled to obtain a diverse sample based on own-
ership, size and type of care provided (nursing, residential
or both). Care home residents prescribed one or more
medicines were then randomly sampled and included if
they provided written, informed consent (assent was
obtained from the next of kin for those lacking
capacity).
A clinical pharmacist inspected three sources to deter-
mine for each resident whether they had a documented
drug sensitivity: i) the medicines administration record, this
chart is used to record the administration of each dose of a
medicine to residents on the drug round, ii) the care home
records, this is a paper-based record for each resident
usually stored in the main office at the care home and iii)
the general practice medical records, which were usually
computerized.These records were then compared and any
discrepancies were identified, recorded and tabulated.
Information describing the nature of any documented sen-
sitivity was also collected.
Results
One hundred and twenty-one residents from 31 care
homes were included in the sample. Table 1 details demo-
graphic and drug sensitivity data. At least one drug sensi-
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tivity was recorded in one of the sources inspected in
31/121 (26%) of residents. There were 48 sensitivities
recorded in total with 20 residents having one sensitivity
recorded and eight, one, one and one residents having
two, three, four and five sensitivities, respectively. Antibiot-
ics accounted for 25/48 (52%) of sensitivities, aspirin/non-
steroidal anti-inflammatory drugs (NSAIDs) 12/48 (25%),
and other drugs 11/48 (23%).
The number of sensitivities recorded on the medicines
administration record, care home record and the general
practice record were 3/48 (6%), 29/48 (60%) and 35/48
(73%), respectively (see Figure 1). Nineteen sensitivities
were recorded in the general practice record but not in the
care record, 13 sensitivities were recorded in the care
record but not in the general practice record and only two
sensitivities were recorded simultaneously on the medi-
cines administration record, care record and the general
practice record.
There was no description of the nature of the sensitivi-
ties recorded in 39/48 (81%) cases. Those that were
recorded are shown in Table 1. Symptoms described
included those that suggested true allergy (e.g. rash, lip
swelling) and those that suggested non-allergic reactions
(e.g. diarrhoea, vomiting).
Discussion
It is of concern that drug sensitivities were not systemati-
cally recorded for these vulnerable residents. Recording
the reaction induced by an offending drug is important to
be able to distinguish between serious allergic reactions
and potentially less harmful reactions or intolerances.
Unfortunately, computer systems (in general practice and
in pharmacies) do not usually distinguish or have the facil-
ity to separate the different types of sensitivities. The
section in which they are classified and coded is often
‘allergies’. Some, but not all, general practice systems allow
the coded sensitivity to have linked free text which can be
used to describe the reaction. However, for four-fifths of
sensitivities no details were documented. In those that
were documented,however, it was often possible to under-
stand the nature of the sensitivity.
There were large discrepancies between the different
records inspected and it is particularly concerning that
over 90% of sensitivities were not recorded on the final
document used for recording the administration of medi-
cines, i.e. the medicines administration record. In nursing
homes, nurses are required to ensure that they do not
administer a medicine to which a resident is allergic or
intolerant of [18]. It is not clear how nurses in care homes
are meeting this standard. There is no guidance or stan-
dards for care staff in residential homes with regards to
checking drug sensitivities. The medicines administration
record is generated by the community pharmacists’ com-
puter software using the patient medication record. It is
clear that information on drug sensitivities is not shared by
Table 1
Demographic data and drug sensitivity status recording
Number of residents 121
Women, number (%) 84 (69%)
Age (years), mean (range) 85.0 (63–101)
Mean number of medicines prescribed (range) 6.8 (1–18)
Number of residents with a documented
sensitivity (%)
31 (26%)
Number of residents with one documented
sensitivity (%)
20 (17%)
Number of residents with two documented
sensitivities (%)
8 (7%)
Number of residents with 3 or more
sensitivities (%)
3 (3%)
Total sensitivities 48
Number of sensitivities documented on
medicines administration record (%)
3 (6.3%)
Number of sensitivities documented in care
record (%)
29 (60%)
Number of sensitivities documented in
general practice record (%)
35 (73%)
Number of sensitivities and reactions recorded
(%)
9 (19%)
Offending drug Recorded reaction
Ibuprofen Rash
Erythromycin Rash
Omeprazole Rash
Lisinopril Lip swelling
Aspirin ‘Red marks on legs’
Cephalexin Diarrhoea and vomiting
Erythromycin Vomiting
Diltiazem Nausea
Paracetamol Nightmares
14
19
0
0
2
1 12
General practice
record
Care home
record
Medicines
administration
record
Figure 1
The number of sensitivities documented in the different records (total
sensitivites = 48)
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the care home or general practice with the community
pharmacy. This is compounded by the fact that care home
residents are remote from the community pharmacy and
less accessible, i.e. they do not visit community pharmacies
and therefore they cannot be asked whether they have a
sensitivity or not.
In general, community pharmacists infrequently visit
the care homes they serve and from the results of this
study, do not appear to be aware of the drug sensitivity
status of residents. Another issue is the fact that care home
residents may have medicines prescribed by visiting
doctors (or other prescribers) who do not have access to
the general practice records. These may include out-of-
hours doctors, community psychiatric staff, dentists and
geriatricians. An improvement in the system is required to
ensure drug sensitivity status is documented on the medi-
cines administration record to avoid the inadvertent
prescription or administration of potentially harmful medi-
cines. This requires the sharing of sensitivity information
with the community pharmacy which will then need to
record this on the patient medication record in order for it
to be printed on the medicines administration record. This
could potentially be achieved by all sensitivities being
automatically printed on prescriptions issued by the
general practitioner. This would need a fairly minor modi-
fication to general practice computer systems which could
probably be made quite simply and without the need for
legislation. It is hoped that it will also be possible to trans-
fer this information electronically with the introduction of
the electronic transfer of prescriptions. However, it should
be recognized that the introduction of technology can
facilitate the introduction of new errors.
Systems should also be in place for care home staff and
community pharmacists to inform the general practitioner
if they are aware of any sensitivities. Key to this is multidis-
ciplinary collaboration and effective interprofessional
communication. The education of prescribers, community
pharmacists and care home staff regarding the recording
of drug sensitivities is also important to address this
problem.
Current guidance from the Royal Pharmaceutical
Society of Great Britain and the Care Quality Commission
does not state that drug sensitivities should be docu-
mented on the medicines administration record and this
should be revised [19, 20]. Practitioners conducting medi-
cation reviews for care home residents should ensure that
drug sensitivities, including their nature and severity, are
documented in all relevant records. In addition, standards
and criteria should be developed so that drug sensitivity
recording can be audited in this setting.
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